JOURNAL OF CLINICAL SURGERY ›› 2026, Vol. 34 ›› Issue (8): 863-868.doi: 10.3969/j.issn.1005-6483.20250414

Previous Articles     Next Articles

The correlation betweenserum V-set and immunoglobulin domain containing 4,protein encoded by the multiple endocrine neoplasia type 1 gene with immune infiltration in patients with papillary thyroid carcinoma and their impact on prognosis

  

  1. Department of General Surgery,Cangzhou Integrated Traditional Chinese and Western Medicine Hospital,Hebei,Cangzhou 061000,China
  • Received:2025-04-18 Accepted:2025-04-18 Online:2026-08-20 Published:2026-08-20

Abstract: Objective To explore the correlation between serum V-set and immunoglobulin domain containing 4 (VSIG4),the protein encoded by the multiple endocrine neoplasia type 1 gene (menin) with immune infiltration in patients with papillary thyroid carcinoma (PTC),and their impact on prognosis.Methods From February 2019 to February 2022,168 PTC patients treated with thyroidectomy (PTC group),168 patients with benign thyroid lesions (benign nodules group),and 168 healthy individuals with normal thyroid function (healthy group) in our hospital were considered as the study subjects.According to whether there was recurrence or death within 3 years after thyroidectomy,the 168 PTC patients were included into 138 cases in the good prognosis group and 30 cases in the poor prognosis group.ELISA method was used to detect serum VSIG4 and menin.Bioinformatics (TISDIB database) was used to explore the correlation between VSIG4,menin,and five types of tumor infiltrating immune cells in PTC patients.Kaplan-Meier survival curves were plotted to explore the relationship between high/low VSIG4,menin levels and disease-free survival.Multifactorial COx method was used to explore the factors influencing the recurrence/death.ROC curve was plotted to evaluate the predictive value of VSIG4 and menin for recurrence/death.Results Serum VSIG4 levels in PTC group,benign nodule group,healthy group were (6.59±1.42)ng/ml,(5.14±1.20)ng/ml,(3.29±0.86)ng/ml respectively,and it was higher in PTC group than the benign nodule group and the healthy group (P<0.05).Serum menin levels in PTC group,benign nodule group,healthy group were (5.02±1.34)ng/ml,(6.47±1.67)ng/ml,(8.15±1.88)ng/ml respectively,and it was lower in PTC group than the benign nodule group and the healthy group (P<0.05).The analysis results of TISDIB database showed that the VSIG4 and menin were correlated with five types of tumor infiltrating immune cells in PTC patients,and the correlation of VSIG4 with immune infiltration in PTC patients was higher than the correlation of menin (P<0.05).The poor prognosis group had prominently higher proportion of lymph node dissection,VSIG4,and proportion of TNM stage Ⅲ,and prominently lower menin than the good prognosis group (P<0.05).The disease-free survival rate of PTC patients with VSIG4 ≥ 6.50ng/ml was greatly lower than that of patients with VSIG4<6.50ng/ml,and the disease-free survival rate of PTC patients with menin ≤ 5.11ng/ml was greatly higher than that of patients with menin>5.11ng/ml (χ2=9.217,16.407,P<0.05).TNM stage Ⅲ and VSIG4 were risk factors for recurrence/death in PTC patients,while menin and lymph node dissection were protective factors (P<0.05).The combined prediction of VSIG4 and menin had an AUC of 0.919 (95%CI 0.868-0.970) for predicting recurrence/death in PTC patients,which was superior to the single prediction of VSIG4 (Z=2.206,P<0.05) and menin (Z=2.376,P<0.05).Conclusion Serum VSIG4 is elevated and menin is reduced in patients with PTC .Both are correlated with five types of tumor infiltrating immune cells in PTC patients.The combined prediction of VSIG4 and menin has a high value in predicting the prognostic recurrence/death in PTC patients.

Key words: V-set and immunoglobulin domain containing 4, protein encoded by the multiple endocrine neoplasia type 1 gene, papillary thyroid carcinoma, immune infiltration, correlation, prognosis

[1] XIA Jun, SUN Liang, WANG Jun, HUANG Yujie. The predictive value of preoperative HALP score for postoperative complications in patients with acute cholecystitis undergoing laparoscopic cholecystectomy [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(8): 880-883.
[2] WANG Hui, XIE Jiaping, ZHAO Jingrun, SUN Dong. Controversies and optimization in the clinical diagnosis and treatment of small gastrointestinal stromal tumors [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(8): 950-954.
[3] LU Jichao, SU Miao, DONG Man. Analysis of risk factors for sarcopenia in patients with primary liver cancer and its impact on prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(7): 757-762.
[4] YANG Yanan,ZHAO He,HE Lingling,WU Dinghua. Correlation and interaction analysis ofneutrophils lymphocytes ratio,C-reactive protein/albumin in peripheral blood and postoperative pulmonary infection in traumatic brain injury [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(6): 627-631.
[5] REN Haifeng,ZHANG Sanhong,DU Lei,WU Mingjun,DANG Miaomiao. Study on the expression of USP10,USP28,and USP35 in lung cancer tissues and their relationship with clinical pathological characteristics and prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(6): 653-657.
[6] WANG Le,WANG Xuewen,LI Xiao,ZHANG Yuting,WANG Danping,SHEN Zhixin. A case of predominantly cystic papillary thyroid carcinoma concurrent with hashimoto’s thyroiditis [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(6): 686-687.
[7] ZHANG Zhibo. The management of intrahepatic bile lake for patients with biliaryatresia [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(5): 486-489.
[8] LIU Zitao, CHEN Menghe, PENG Pai, SHEN Haoyuan, HU Chaohua. Expression and significance of CXCR4 and SDF1 in triple-negative breast cancer tissues [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(5): 506-511.
[9] ZHAO Haonan, WANG Jiamin, JIN Ruotian. The Relationship Between Serum C-X-C chemokine receptor 7 and solute carrier family 7 member 11 with cancer pathological features and patient prognosis in gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(5): 518-522.
[10] HOU Wen, YU Hongxia, PAN Yuting, DUAN Jiali, YUN Hong. Efficacy analysis of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in young patients with peritoneal metastasis of colorectal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(5): 550-555.
[11] XU Jijing, LI Jiaxuan, CAO Ronghua, HUANG Yonggao. Effect of spread through air spaces (STAS) of lung adenocarcinoma on the selection of lobectomy and sublobar resection and postoperative survival outcomes [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(4): 407-411.
[12] XU Shaowei*,JIAN Weihua,CHEN Zhen,FENG Jianhua,CAI Wensong,XU Bo. Notableissues in papillary thyroid carcinoma with ipsilateral lateral neck lymph node metastasis [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(3): 245-248.
[13] GAO Zhenghong,XU Bo,CAI Wensong. Applicationstatus of ultrasonic elastography and AI-assisted diagnosis in active surveillance for low-risk papillary thyroid carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(3): 258-261.
[14] CHE Shenghan*,WANG Bing,LI Chen,JIAN Yanbing,SHI Chenlei,QIN Huadong,YANG Zelong,ZHANG Linlin,MENG Xianying,YAO Jing,TIAN Wen. Clinical effect analysis of endoscopic surgery via three-port gasless intermuscular approach for papillary thyroid carcinoma at cN0 stage [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(3): 262-266.
[15] WANG Ruoxue,LIU Xin,LI Xiaoqing,XU Yize,ZHENG Dong,MA Ce,AN Yunheng. Diagnostic value of galactin-3andstromal cell derived factor-1 combined with ultrasound elastography in papillary thyroid carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2026, 34(3): 267-271.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 753 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 796 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 821 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 835 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 841 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 867 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 888 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(12): 916 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(12): 919 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(12): 946 .